Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.
Smith
L A
LA
Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida 33617, USA.
Ignacio
J R A
JR
Winesett
M P
MP
Kaiser
G C
GC
Lacson
A G
AG
Gilbert-Barness
E
E
González-Peralta
R P
RP
Wilsey
M J
MJ
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001649:Bile Duct Diseases / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D002648:Child; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014580:Ursodeoxycholic Acid; D019980:Amoxicillin-Potassium Clavulanate Combination